Granite Investment Partners’s Harvard Bioscience HBIO Stock Holding History

Granite Investment Partners’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-22,119	Closed	-$1.26M	–	300
2015 Q2	$1.26M	Sell	22,119 -5,602	-20%	-$319K	0.12%	191
2015 Q1	$1.61M	Buy	27,721 +7,832	+39%	+$421K	0.14%	180
2014 Q4	$1.13M	Buy	19,889 +11,466	+136%	+$546K	0.13%	192
2014 Q3	$344K	Buy	+8,423	New	+$387K	0.05%	251

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Granite Investment Partners's HBIO Position: Q3 2015 in Review

Granite Investment Partners sold out of Harvard Bioscience (HBIO) in Q3 2015, closing a stake of 22,119 shares — an estimated $1.26M sold.

Granite Investment Partners first reported a position in HBIO in Q3 2014 and held it in 4 quarters. The position peaked at $1.61M in Q1 2015. 84 funds tracked by Wall St. Rank hold HBIO as of Q3 2015.

Granite Investment Partners reported no remaining Harvard Bioscience position as of Q3 2015 after selling out during the quarter.
Granite Investment Partners sold 22,119 Harvard Bioscience shares in Q3 2015, an estimated $1.26M.
Granite Investment Partners first reported a position in Harvard Bioscience in Q3 2014 and held it in 4 quarters.
Granite Investment Partners's Harvard Bioscience position peaked at $1.61M in Q1 2015.
84 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2015.

Based on Granite Investment Partners's 13F filing for Q3 2015, filed 12 Nov 2015.